A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.
A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease.
Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.
G-protein coupled receptors that are formed through the dimerization of the CALCITONIN RECEPTOR with a RECEPTOR ACTIVITY-MODIFYING PROTEIN. Their affinity for ISLET AMYLOID POLYPEPTIDE is dependent upon which of several receptor activity-modifying protein subtypes they are bound to.
Endocrine cells found throughout the GASTROINTESTINAL TRACT and in islets of the PANCREAS. D cells secrete SOMATOSTATIN that acts in both an endocrine and paracrine manner. Somatostatin acts on a variety of tissues including the PITUITARY GLAND; gastrointestinal tract; pancreas; and KIDNEY by inhibiting the release of hormones, such as GROWTH HORMONE; GASTRIN; INSULIN; and RENIN.
An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
An acid dye used in testing for hydrochloric acid in gastric contents. It is also used histologically to test for AMYLOIDOSIS.
A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
A type of pancreatic cell representing about 5-20% of the islet cells. Alpha cells secrete GLUCAGON.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
An individual having only one allele at a given locus because of the loss of the other allele through a mutation (e.g., CHROMOSOME DELETION).
A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
Isomeric forms and derivatives of PROPANOL (C3H7OH).
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Electron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen.
A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice.
Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology.
The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices, beta strands (which align to form beta sheets) or other types of coils. This is the first folding level of protein conformation.
The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
Thiazoles are heterocyclic organic compounds containing a sulfur atom and a nitrogen atom, which are bound by two carbon atoms to form a five-membered ring, and are widely found in various natural and synthetic substances, including some pharmaceuticals and vitamins.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.
Processes involved in the formation of TERTIARY PROTEIN STRUCTURE.
Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.
A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.
A type of scanning probe microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. These deflections produce a topographic map of the sample.

Interaction of amylin with calcitonin gene-related peptide receptors in the microvasculature of the hamster cheek pouch in vivo. (1/35)

1. This study used intravital microscopy to investigate the receptors stimulated by amylin which shares around 50% sequence homology with the vasodilator calcitonin gene-related peptide (CGRP) in the hamster cheek pouch microvasculature in vivo. 2. Receptor agonists dilated arterioles (diameters 20-40 microm). The -log of the concentrations (+/- s.e.mean; n = 8) causing 50% increase in arteriole diameter were: human betaCGRP (10.8 +/- 0.3), human alphaCGRP (10.8 +/- 0.4), rat alphaCGRP (10.4 +/- 0.3). Rat amylin and the CGRP2 receptor selective agonist [Cys(ACM2,7]-human alphaCGRP were 100 fold less potent (estimates were 8.5 +/- 0.4 and 8.2 +/- 0.3 respectively). 3. The GCRP1 receptor antagonist, CGRP8-37 (300 nmol kg(-1); i.v.) reversibly inhibited the increase in diameter evoked by human alphaCGRP (0.3 nM) from 178 +/- 22% to 59 +/- 12% (n = 8; P < 0.05) and by rat amylin (100 nM) from 138 +/- 23% to 68 +/- 24% (n = 6; P < 0.05). CGRP8-37 did not inhibit vasodilation evoked by substance P (10 nM; n = 4: P > 0.05). 4. The amylin receptor antagonist, amylin8-37 (300 nmol kg(-1); i.v.) did not significantly inhibit the increase in diameter evoked by human alphaCGRP (0.3 nM) which was 112 +/- 26% in the absence, and 90 +/- 29% in the presence of antagonist (n = 4; P < 0.05); nor that evoked by rat amylin (100 nM) which was 146 +/- 23% in the absence and 144 +/- 32% in the presence of antagonist (n = 4; P > 0.05). 5. The agonist profile for vasodilatation and the inhibition of this dilatation by CGRP8-37, although not the amylin8-37 indicates that amylin causes vasodilatation through interaction with CGRP1 receptors in the hamster cheek pouch.  (+info)

Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. (2/35)

Receptor activity-modifying proteins (RAMPs) are single-transmembrane proteins that transport the calcitonin receptor-like receptor (CRLR) to the cell surface. RAMP 1-transported CRLR is a calcitonin gene-related peptide (CGRP) receptor. RAMP 2- or RAMP 3-transported CRLR is an adrenomedullin receptor. The role of RAMPs beyond their interaction with CRLR, a class II G protein-coupled receptor, is unclear. In this study, we have examined the role of RAMPs in generating amylin receptor phenotypes from the calcitonin (CT) receptor gene product. Cotransfection of RAMP 1 or RAMP 3 with the human CT receptor lacking the 16-amino acid insert in intracellular domain 1 (hCTRI1-) into COS-7 cells induced specific 125I-labeled rat amylin binding. RAMP 2 or vector cotransfection did not cause significant increases in specific amylin binding. Competition-binding characterization of the RAMP-induced amylin receptors revealed two distinct phenotypes. The RAMP 1-derived amylin receptor demonstrated the highest affinity for salmon CT (IC50, 3.01 +/- 1.44 x 10(-10) M), a high to moderate affinity for rat amylin (IC50, 7.86 +/- 4.49 x 10(-9) M) and human CGRPalpha (IC50, 2.09 +/- 1.63 x 10(-8) M), and a low affinity for human CT (IC50, 4.47 +/- 0.78 x 10(-7) M). In contrast, whereas affinities for amylin and the CTs were similar for the RAMP 3-derived receptor, the efficacy of human CGRPalpha was markedly reduced (IC50, 1.12 +/- 0.45 x 10(-7) M; P <.05 versus RAMP 1). Functional cyclic AMP responses in COS-7 cells cotransfected with individual RAMPs and hCTRI1- were reflective of the phenotypes seen in competition for amylin binding. Confocal microscopic localization of c-myc-tagged RAMP 1 indicated that, when transfected alone, RAMP 1 almost exclusively was located intracellularly. Cotransfection with calcitonin receptor (CTR)I1- induced cell surface expression of RAMP 1. The results of experiments cross-linking 125I-labeled amylin to RAMP 1/hCTR-transfected cells with bis succidimidyl suberate were suggestive of a cell-surface association of RAMP 1 and the receptors. Our data suggest that in the CT family of receptors, and potentially in other class II G protein-coupled receptors, the cellular phenotype is likely to be dynamic in regard to the level and combination of both the receptor and the RAMP proteins.  (+info)

Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. (3/35)

To examine whether islet amyloid polypeptide (IAPP), other than through amyloid formation, may be of importance in diabetes pathogenesis, IAPP-deficient mice (IAPP(-/-)) were challenged with alloxan (day 0). Diabetes in IAPP(-/-) mice was more severe at day 35, indicated by greater weight loss; glucose levels were higher in alloxan-treated IAPP(-/-) mice, whereas insulin levels were lower, indicating a greater impairment of islet function. Accordingly, glucose levels upon intravenous glucose challenges at days 7 and 35 were consistently higher in alloxan-treated IAPP(-/-) mice. At day 35, insulin mRNA expression, but not beta-cell mass, was lower in untreated IAPP(-/-) mice. Yet, upon alloxan administration, beta-cell mass and numbers of beta-cell-containing islets were significantly more reduced in IAPP(-/-) mice. Furthermore, they displayed exaggerated beta-cell dysfunction, because in their remaining beta-cells, insulin mRNA expression was significantly more impaired and the localization of glucose transporter-2 was perturbed. Thus the lack of IAPP has allowed exaggerated beta-cell cytotoxic actions of alloxan, suggesting that there may be beneficial features of IAPP actions in situations of beta-cell damage.  (+info)

Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. (4/35)

Receptor activity modifying proteins (RAMPs) constitute a group of three proteins, designated as RAMP1, 2, and 3, which are able to effect functional changes in some members of the G protein-coupled receptor family. Thus, RAMP1 or RAMP3 can modify the calcitonin receptor (CTR) to also function as a high-affinity amylin receptor-like phenotype. To examine the RAMP/CTR interaction, individual RAMPs were coexpressed with either of the two human CTR (hCTR) isoforms, the insert negative (hCTR(I1-)) or the insert positive (hCTR(I1+)), in Chinese hamster ovary (CHO-P) or African monkey kidney (COS-7) cells. CHO-P cells provide an environment conducive to a low, but significant, level of amylin binding with either hCTR isoform alone, unlike in COS-7, where RAMP coexpression is imperative for amylin binding. Also, in CHO-P, hCTR(I1-) induced amylin binding with all three RAMPs, in contrast to COS-7, where only RAMP1 or RAMP3 generate an amylin receptor phenotype. hCTR(I1+) induced high-affinity amylin binding with any RAMP in either cell line. In COS-7 cells, hCTR(I1+)/RAMP-generated receptor displayed high- and low-affinity states, in contrast with the single-state binding seen with hCTR(I1-)/RAMP-generated receptor, whereas in CHO-P cells a two-affinity state receptor phenotype was evident with both hCTR isoforms. Endogenous RAMP expression is low and similar between cell lines. The results suggest that CTR/RAMP interaction in these cells is complex with other cellular factors such as the levels of different G proteins and/or receptor/RAMP stoichiometry following heterologous coexpression contributing to the ultimate receptor phenotype.  (+info)

International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. (5/35)

The calcitonin family of peptides comprises calcitonin, amylin, two calcitonin gene-related peptides (CGRPs), and adrenomedullin. The first calcitonin receptor was cloned in 1991. Its pharmacology is complicated by the existence of several splice variants. The receptors for the other members the family are made up of subunits. The calcitonin-like receptor (CL receptor) requires a single transmembrane domain protein, termed receptor activity modifying protein, RAMP1, to function as a CGRP receptor. RAMP2 and -3 enable the same CL receptor to behave as an adrenomedullin receptor. Although the calcitonin receptor does not require RAMP to bind and respond to calcitonin, it can associate with the RAMPs, resulting in a series of receptors that typically have high affinity for amylin and varied affinity for CGRP. This review aims to reconcile what is observed when the receptors are reconstituted in vitro with the properties they show in native cells and tissues. Experimental conditions must be rigorously controlled because different degrees of protein expression may markedly modify pharmacology in such a complex situation. Recommendations, which follow International Union of Pharmacology guidelines, are made for the nomenclature of these multimeric receptors.  (+info)

Human amylin actions on rat cholinergic basal forebrain neurons: antagonism of beta-amyloid effects. (6/35)

Human amylin (hAmylin), a 37-amino acid pancreatic peptide, and amyloid beta protein (A beta), a 39-43 amino acid peptide, abundantly deposited in the brains of Alzheimer's patients, induce neurotoxicity in hippocampal and cortical cultures. Although the mechanism of this neurotoxicity is unknown, both peptides are capable of modulating ion channel function that may result in a disruption of cellular homeostasis. In this study, we examined the effects of hAmylin on whole cell currents in chemically identified neurons from the rat basal forebrain and the interactions of hAmylin-induced responses with those of A beta. Whole cell patch-clamp recordings were performed on enzymatically dissociated neurons of the diagonal band of Broca (DBB), a cholinergic basal forebrain nucleus. Bath application of hAmylin (1 nM to 5 microM) resulted in a dose-dependent reduction in whole cell currents in a voltage range between -30 and +30 mV. Single-cell RT-PCR analysis reveal that all DBB neurons responding to hAmylin or A beta were cholinergic. Using specific ion channel blockers, we identified hAmylin and A beta effects on whole cell currents to be mediated, in part, by calcium-dependent conductances. Human amylin also depressed the transient outward (IA) and the delayed rectifier (IK) potassium currents. The hAmylin effects on whole cell currents could be occluded by A beta and vice versa. Human amylin and A beta responses could be blocked with AC187 (50 nM to 1 microM), a specific antagonist for the amylin receptor. The present study indicates that hAmylin, like A beta, is capable of modulating ion channel function in cholinergic basal forebrain neurons. Furthermore, the two peptides may share a common mechanism of action. The ability of an amylin antagonist to block the responses evoked by hAmylin and A beta may provide a novel therapeutic approach for Alzheimer's disease.  (+info)

Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons. (7/35)

Salvage of cholinergic neurons in the brain through a blockade of the neurotoxic effects of amyloidbeta protein (Abeta) is one of the major, but still elusive, therapeutic goals of current research in Alzheimer's disease (AD). To date, no receptor has been unequivocally identified for Abeta. Human amylin, which acts via a receptor composed of the calcitonin receptor-like receptor and a receptor-associated membrane protein, possesses amyloidogenic properties and has a profile of neurotoxicity that is strikingly similar to Abeta. In this study, using primary cultures of rat cholinergic basal forebrain neurons, we show that acetyl-[Asn30, Tyr32] sCT(8-37) (AC187), an amylin receptor antagonist, blocks Abeta-induced neurotoxicity. Treatment of cultures with AC187 before exposure to Abeta results in significantly improved neuronal survival as judged by MTT and live-dead cell assays. Quantitative measures of Abeta-evoked apoptotic cell death, using Hoechst and phosphotidylserine staining, confirm neuroprotective effects of AC187. We also demonstrate that AC187 attenuates the activation of initiator and effector caspases that mediate Abeta-induced apoptotic cell death. These data are the first to show that expression of Abeta toxicity may occur through the amylin receptor and suggest a novel therapeutic target for the treatment of AD.  (+info)

Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. (8/35)

Calcitonin (CT) receptors dimerize with receptor activity-modifying proteins (RAMPs) to create high-affinity amylin (AMY) receptors, but there is no reliable means of pharmacologically distinguishing these receptors. We used agonists and antagonists to define their pharmacology, expressing the CT(a) receptor alone or with RAMPs in COS-7 cells and measuring cAMP accumulation. Intermedin short, otherwise known as adrenomedullin 2, mirrored the action of alpha CGRP, being a weak agonist at CT(a), AMY(2a), and AMY(3a) receptors but considerably more potent at AMY(1a) receptors. Likewise, the linear calcitonin gene-related peptide (CGRP) analogs (Cys(ACM)(2,7))h alpha CGRP and (Cys(Et)(2,7))h alpha CGRP were only effective at AMY(1a) receptors, but they were partial agonists. As previously observed in COS-7 cells, there was little induction of the AMY(2a) receptor phenotype; thus, AMY(2a) was not examined further in this study. The antagonist peptide salmon calcitonin(8-32) (sCT(8-32)) did not discriminate strongly between CT and AMY receptors; however, AC187 was a more effective antagonist of AMY responses at AMY receptors, and AC413 additionally showed modest selectivity for AMY(1a) over AMY(3a) receptors. CGRP(8-37) also demonstrated receptor-dependent effects. CGRP(8-37) more effectively antagonized AMY at AMY(1a) than AMY(3a) receptors, although it was only a weak antagonist of both, but it did not inhibit responses at the CT(a) receptor. Low CGRP(8-37) affinity and agonism by linear CGRP analogs at AMY(1a) are the classic signature of a CGRP2 receptor. Our data indicate that careful use of combinations of agonists and antagonists may allow pharmacological discrimination of CT(a), AMY(1a), and AMY(3a) receptors, providing a means to delineate the physiological significance of these receptors.  (+info)

Islet Amyloid Polypeptide (IAPP), also known as amylin, is a 37-amino acid peptide co-secreted with insulin from pancreatic beta-cells in response to meals. It plays crucial roles in regulating glucose homeostasis by suppressing glucagon secretion, slowing gastric emptying, and promoting satiety. In type 2 diabetes, IAPP can form amyloid fibrils, which deposit in pancreatic islets, contributing to beta-cell dysfunction and death. This contributes to the progressive nature of type 2 diabetes.

Amyloid is a term used in medicine to describe abnormally folded protein deposits that can accumulate in various tissues and organs of the body. These misfolded proteins can form aggregates known as amyloid fibrils, which have a characteristic beta-pleated sheet structure. Amyloid deposits can be composed of different types of proteins, depending on the specific disease associated with the deposit.

In some cases, amyloid deposits can cause damage to organs and tissues, leading to various clinical symptoms. Some examples of diseases associated with amyloidosis include Alzheimer's disease (where amyloid-beta protein accumulates in the brain), systemic amyloidosis (where amyloid fibrils deposit in various organs such as the heart, kidneys, and liver), and type 2 diabetes (where amyloid deposits form in the pancreas).

It's important to note that not all amyloid deposits are harmful or associated with disease. However, when they do cause problems, treatment typically involves managing the underlying condition that is leading to the abnormal protein accumulation.

The Islets of Langerhans are clusters of specialized cells within the pancreas, an organ located behind the stomach. These islets are named after Paul Langerhans, who first identified them in 1869. They constitute around 1-2% of the total mass of the pancreas and are distributed throughout its substance.

The Islets of Langerhans contain several types of cells, including:

1. Alpha (α) cells: These produce and release glucagon, a hormone that helps to regulate blood sugar levels by promoting the conversion of glycogen to glucose in the liver when blood sugar levels are low.
2. Beta (β) cells: These produce and release insulin, a hormone that promotes the uptake and utilization of glucose by cells throughout the body, thereby lowering blood sugar levels.
3. Delta (δ) cells: These produce and release somatostatin, a hormone that inhibits the release of both insulin and glucagon and helps regulate their secretion in response to changing blood sugar levels.
4. PP cells (gamma or γ cells): These produce and release pancreatic polypeptide, which plays a role in regulating digestive enzyme secretion and gastrointestinal motility.

Dysfunction of the Islets of Langerhans can lead to various endocrine disorders, such as diabetes mellitus, where insulin-producing beta cells are damaged or destroyed, leading to impaired blood sugar regulation.

Islet amyloid polypeptide receptors (IAPRs) are a type of G protein-coupled receptor (GPCR) that play a role in the regulation of glucose homeostasis and energy balance. They are activated by the hormone islet amyloid polypeptide (IAPP), also known as amylin, which is co-secreted with insulin from pancreatic beta cells in response to meals.

There are two subtypes of IAPRs, named RCS3 (or IA PR1) andRAMP2 (or IA PR2). These receptors can form heterodimers with other GPCRs, such as the calcitonin receptor (CTR), to form functional complexes that bind IAPP with high affinity. Activation of IAPRs by IAPP has been shown to inhibit gastric emptying, reduce food intake, and lower blood glucose levels, suggesting a role in the regulation of satiety and glucose metabolism.

Mutations in the genes encoding IAPP and IAPRs have been associated with the development of type 2 diabetes, suggesting that dysfunction of the IAPP/IAPR system may contribute to the pathogenesis of this disease. Additionally, the accumulation of misfolded IAPP in pancreatic islets can lead to the formation of amyloid deposits, which are a characteristic feature of type 2 diabetes and have been implicated in the destruction of beta cells and the development of insulin resistance.

Somatostatin-secreting cells, also known as delta cells or D cells, are a type of neuroendocrine cell found in the pancreatic islets and the central nervous system. These cells produce and secrete somatostatin, a peptide hormone that inhibits the release of several other hormones such as insulin, glucagon, and gastrin.

Somatostatin has a wide range of physiological effects, including inhibition of gastrointestinal motility, secretion, and blood flow; modulation of neurotransmission; and regulation of cell growth and differentiation. Somatostatin-secreting cells play an essential role in maintaining hormonal homeostasis by regulating the release of other hormones in response to various physiological stimuli.

In the pancreas, somatostatin-secreting cells are located in the islets of Langerhans, where they represent about 10% of the endocrine cell population. They are scattered among the insulin-producing beta cells and glucagon-producing alpha cells and form a dense network of fine processes that surround other islet cells. Somatostatin released from these cells acts in a paracrine manner to regulate the secretion of insulin, glucagon, and other hormones produced by the islet cells.

In the central nervous system, somatostatin-secreting cells are found in various regions, including the hypothalamus, hippocampus, and cortex. They play a role in regulating neurotransmission, neuronal excitability, and synaptic plasticity. Dysfunction of somatostatin-secreting cells has been implicated in several neurological and endocrine disorders, such as diabetes, acromegaly, and certain types of tumors.

A glucagonoma is a rare type of neuroendocrine tumor that originates from the alpha cells of the pancreas, where the hormone glucagon is produced. This tumor can lead to an overproduction of glucagon, resulting in a characteristic syndrome known as the "glucagonoma syndrome."

The symptoms of glucagonoma syndrome may include:

1. A distinctive rash called necrolytic migratory erythema, which is characterized by red, swollen, and painful skin lesions that can affect various parts of the body.
2. Weight loss
3. Diabetes or high blood sugar levels (hyperglycemia)
4. Anemia
5. Deep vein thrombosis (blood clots in the deep veins)
6. Depression and confusion
7. A decreased appetite
8. Fatigue and weakness
9. Diarrhea or steatorrhea (fatty stools)
10. High levels of amino acids, fatty acids, and zinc in the blood.

Glucagonomas are typically slow-growing tumors, but they can metastasize (spread) to other organs such as the liver, lymph nodes, and bones. Treatment options for glucagonoma may include surgery to remove the tumor, chemotherapy, targeted therapy, or radiation therapy. Regular follow-up care is essential to monitor the tumor's progression and manage any associated symptoms.

Insulin-secreting cells, also known as beta cells, are a type of cell found in the pancreas. They are responsible for producing and releasing insulin, a hormone that regulates blood glucose levels by allowing cells in the body to take in glucose from the bloodstream. Insulin-secreting cells are clustered together in the pancreatic islets, along with other types of cells that produce other hormones such as glucagon and somatostatin. In people with diabetes, these cells may not function properly, leading to an impaired ability to regulate blood sugar levels.

Congo Red is a synthetic diazo dye that is commonly used in histology and pathology for stainings and tests. It is particularly useful in identifying amyloid deposits in tissues, which are associated with various diseases such as Alzheimer's disease, type 2 diabetes, and systemic amyloidosis.

When Congo Red binds to amyloid fibrils, it exhibits a characteristic apple-green birefringence under polarized light microscopy. Additionally, Congo Red stained amyloid deposits show a shift in their emission spectrum when excited with circularly polarized light, a phenomenon known as dichroism. These properties make Congo Red a valuable tool for the diagnosis and study of amyloidosis and other protein misfolding disorders.

It is important to note that Congo Red staining should be performed with care, as it can be toxic and carcinogenic if not handled properly.

Insulinoma is a rare type of neuroendocrine tumor that originates from the beta cells of the pancreatic islets (islets of Langerhans). These tumors produce and secrete excessive amounts of insulin, leading to hypoglycemia (low blood sugar levels) even when the person hasn't eaten for a while. Insulinomas are typically slow-growing and benign (noncancerous), but about 10% of them can be malignant (cancerous) and may spread to other parts of the body. Common symptoms include sweating, confusion, dizziness, and weakness due to low blood sugar levels. The diagnosis is often confirmed through imaging tests like CT scans or MRI, and measuring insulin and C-peptide levels in the blood during a fasting test. Treatment usually involves surgical removal of the tumor.

Glucagon-secreting cells, also known as alpha (α) cells, are a type of cell located in the pancreatic islets of Langerhans. These cells are responsible for producing and secreting the hormone glucagon, which plays a crucial role in regulating blood glucose levels.

Glucagon works in opposition to insulin, another hormone produced by different cells in the pancreas called beta (β) cells. When blood glucose levels are low, such as during fasting or exercise, glucagon is released into the bloodstream and travels to the liver, where it stimulates the breakdown of glycogen (stored glucose) into glucose, which is then released into the bloodstream to raise blood glucose levels.

Abnormalities in glucagon-secreting cells can contribute to various endocrine disorders, such as diabetes and hypoglycemia.

Diabetes Mellitus, Type 2 is a metabolic disorder characterized by high blood glucose (or sugar) levels resulting from the body's inability to produce sufficient amounts of insulin or effectively use the insulin it produces. This form of diabetes usually develops gradually over several years and is often associated with older age, obesity, physical inactivity, family history of diabetes, and certain ethnicities.

In Type 2 diabetes, the body's cells become resistant to insulin, meaning they don't respond properly to the hormone. As a result, the pancreas produces more insulin to help glucose enter the cells. Over time, the pancreas can't keep up with the increased demand, leading to high blood glucose levels and diabetes.

Type 2 diabetes is managed through lifestyle modifications such as weight loss, regular exercise, and a healthy diet. Medications, including insulin therapy, may also be necessary to control blood glucose levels and prevent long-term complications associated with the disease, such as heart disease, nerve damage, kidney damage, and vision loss.

A hemizygote is an individual or a cell that has only one copy of a particular gene, as opposed to the usual two copies (one from each parent) in a diploid organism. This condition typically occurs when the gene is located on a sex chromosome (X or Y). For example, males in humans are hemizygous for all genes located on the X chromosome since they have only one X chromosome and one Y chromosome. If a recessive allele is present on the X chromosome of a male, he will express that trait because there is no corresponding allele to mask its effect. In contrast, females have two X chromosomes and would need to inherit two copies of the recessive allele to express the trait.

Amyloidosis is a medical condition characterized by the abnormal accumulation of insoluble proteins called amyloid in various tissues and organs throughout the body. These misfolded protein deposits can disrupt the normal function of affected organs, leading to a range of symptoms depending on the location and extent of the amyloid deposition.

There are different types of amyloidosis, classified based on the specific proteins involved:

1. Primary (AL) Amyloidosis: This is the most common form, accounting for around 80% of cases. It results from the overproduction and misfolding of immunoglobulin light chains, typically by clonal plasma cells in the bone marrow. The amyloid deposits can affect various organs, including the heart, kidneys, liver, and nervous system.
2. Secondary (AA) Amyloidosis: This form is associated with chronic inflammatory diseases, such as rheumatoid arthritis, tuberculosis, or familial Mediterranean fever. The amyloid fibrils are composed of serum amyloid A protein (SAA), an acute-phase reactant produced during the inflammatory response. The kidneys are commonly affected in this type of amyloidosis.
3. Hereditary or Familial Amyloidosis: These forms are caused by genetic mutations that result in the production of abnormal proteins prone to misfolding and amyloid formation. Examples include transthyretin (TTR) amyloidosis, fibrinogen amyloidosis, and apolipoprotein AI amyloidosis. These forms can affect various organs, including the heart, nerves, and kidneys.
4. Dialysis-Related Amyloidosis: This form is seen in patients undergoing long-term dialysis for chronic kidney disease. The amyloid fibrils are composed of beta-2 microglobulin, a protein that accumulates due to impaired clearance during dialysis. The joints and bones are commonly affected in this type of amyloidosis.

The diagnosis of amyloidosis typically involves a combination of clinical evaluation, imaging studies, and tissue biopsy with the demonstration of amyloid deposition using special stains (e.g., Congo red). Treatment depends on the specific type and extent of organ involvement and may include supportive care, medications to target the underlying cause (e.g., chemotherapy, immunomodulatory agents), and organ transplantation in some cases.

"Propanols" is a general term that refers to a class of alcohols containing a propanol group, which is a functional group made up of a carbon atom bonded to three hydrogen atoms and a hydroxyl group (-OH). There are two primary structures for propanols: 1-propanol (n-propyl alcohol) and 2-propanol (isopropyl alcohol), which differ in the arrangement of their carbon chain.

1-Propanol, also known as n-propyl alcohol, has a linear structure with the hydroxyl group attached to one end of the carbon chain: CH3CH2CH2OH. It is a colorless liquid that is used as a solvent and in the production of other chemicals.

2-Propanol, also known as isopropyl alcohol or isopropanol, has a branched structure with the hydroxyl group attached to a branch on the second carbon atom: (CH3)2CHOH. It is a colorless, flammable liquid that is widely used as a solvent and disinfectant.

Both 1-propanol and 2-propanol have applications in various industries, including pharmaceuticals, cosmetics, and cleaning products. However, they should be handled with care due to their flammability and potential health hazards, such as irritation of the eyes, skin, and respiratory tract.

Somatostatin is a hormone that inhibits the release of several hormones and also has a role in slowing down digestion. It is produced by the body in various parts of the body, including the hypothalamus (a part of the brain), the pancreas, and the gastrointestinal tract.

Somatostatin exists in two forms: somatostatin-14 and somatostatin-28, which differ in their length. Somatostatin-14 is the predominant form found in the brain, while somatostatin-28 is the major form found in the gastrointestinal tract.

Somatostatin has a wide range of effects on various physiological processes, including:

* Inhibiting the release of several hormones such as growth hormone, insulin, glucagon, and gastrin
* Slowing down digestion by inhibiting the release of digestive enzymes from the pancreas and reducing blood flow to the gastrointestinal tract
* Regulating neurotransmission in the brain

Somatostatin is used clinically as a diagnostic tool for detecting certain types of tumors that overproduce growth hormone or other hormones, and it is also used as a treatment for some conditions such as acromegaly (a condition characterized by excessive growth hormone production) and gastrointestinal disorders.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Glucagon is a hormone produced by the alpha cells of the pancreas. Its main function is to regulate glucose levels in the blood by stimulating the liver to convert stored glycogen into glucose, which can then be released into the bloodstream. This process helps to raise blood sugar levels when they are too low, such as during hypoglycemia.

Glucagon is a 29-amino acid polypeptide that is derived from the preproglucagon protein. It works by binding to glucagon receptors on liver cells, which triggers a series of intracellular signaling events that lead to the activation of enzymes involved in glycogen breakdown.

In addition to its role in glucose regulation, glucagon has also been shown to have other physiological effects, such as promoting lipolysis (the breakdown of fat) and inhibiting gastric acid secretion. Glucagon is often used clinically in the treatment of hypoglycemia, as well as in diagnostic tests to assess pancreatic function.

Protein multimerization refers to the process where multiple protein subunits assemble together to form a complex, repetitive structure called a multimer or oligomer. This can involve the association of identical or similar protein subunits through non-covalent interactions such as hydrogen bonding, ionic bonding, and van der Waals forces. The resulting multimeric structures can have various shapes, sizes, and functions, including enzymatic activity, transport, or structural support. Protein multimerization plays a crucial role in many biological processes and is often necessary for the proper functioning of proteins within cells.

Insulin is a hormone produced by the beta cells of the pancreatic islets, primarily in response to elevated levels of glucose in the circulating blood. It plays a crucial role in regulating blood glucose levels and facilitating the uptake and utilization of glucose by peripheral tissues, such as muscle and adipose tissue, for energy production and storage. Insulin also inhibits glucose production in the liver and promotes the storage of excess glucose as glycogen or triglycerides.

Deficiency in insulin secretion or action leads to impaired glucose regulation and can result in conditions such as diabetes mellitus, characterized by chronic hyperglycemia and associated complications. Exogenous insulin is used as a replacement therapy in individuals with diabetes to help manage their blood glucose levels and prevent long-term complications.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Transmission electron microscopy (TEM) is a type of microscopy in which an electron beam is transmitted through a ultra-thin specimen, interacting with it as it passes through. An image is formed from the interaction of the electrons with the specimen; the image is then magnified and visualized on a fluorescent screen or recorded on an electronic detector (or photographic film in older models).

TEM can provide high-resolution, high-magnification images that can reveal the internal structure of specimens including cells, viruses, and even molecules. It is widely used in biological and materials science research to investigate the ultrastructure of cells, tissues and materials. In medicine, TEM is used for diagnostic purposes in fields such as virology and bacteriology.

It's important to note that preparing a sample for TEM is a complex process, requiring specialized techniques to create thin (50-100 nm) specimens. These include cutting ultrathin sections of embedded samples using an ultramicrotome, staining with heavy metal salts, and positive staining or negative staining methods.

Pancreatic polypeptide (PP) is a hormone that is produced and released by the pancreas, specifically by the F cells located in the islets of Langerhans. It is a small protein consisting of 36 amino acids, and it plays a role in regulating digestive functions, particularly by inhibiting pancreatic enzyme secretion and gastric acid secretion.

PP is released into the bloodstream in response to food intake, especially when nutrients such as proteins and fats are present in the stomach. It acts on the brain to produce a feeling of fullness or satiety, which helps to regulate appetite and eating behavior. Additionally, PP has been shown to have effects on glucose metabolism, insulin secretion, and energy balance.

In recent years, there has been growing interest in the potential therapeutic uses of PP for a variety of conditions, including obesity, diabetes, and gastrointestinal disorders. However, more research is needed to fully understand its mechanisms of action and clinical applications.

Lissamine Green Dyes are a type of diagnostic dye used in ophthalmology to assess the health and integrity of the tear film and the corneal surface. These dyes have a green color and are often used in conjunction with other dyes like fluorescein. When applied to the eye, Lissamine Green Dyes selectively stain areas of the eye that have been damaged or disrupted, such as areas of dryness, irritation, or inflammation.

The dye binds to denatured proteins and cellular debris on the surface of the eye, highlighting any abnormalities in the tear film or corneal epithelium. Lissamine Green Dyes can help diagnose conditions such as dry eye syndrome, exposure keratopathy, and corneal abrasions. The dye is generally considered safe for use in diagnostic procedures, but it should be used with caution and according to proper protocols to minimize any potential risks or discomfort to the patient.

Secondary protein structure refers to the local spatial arrangement of amino acid chains in a protein, typically described as regular repeating patterns held together by hydrogen bonds. The two most common types of secondary structures are the alpha-helix (α-helix) and the beta-pleated sheet (β-sheet). In an α-helix, the polypeptide chain twists around itself in a helical shape, with each backbone atom forming a hydrogen bond with the fourth amino acid residue along the chain. This forms a rigid rod-like structure that is resistant to bending or twisting forces. In β-sheets, adjacent segments of the polypeptide chain run parallel or antiparallel to each other and are connected by hydrogen bonds, forming a pleated sheet-like arrangement. These secondary structures provide the foundation for the formation of tertiary and quaternary protein structures, which determine the overall three-dimensional shape and function of the protein.

Islets of Langerhans transplantation is a surgical procedure that involves the transplantation of isolated islets from a deceased donor's pancreas into another person with type 1 diabetes. The islets of Langerhans are clusters of cells within the pancreas that produce hormones, including insulin, which regulates blood sugar levels.

In type 1 diabetes, the body's immune system mistakenly attacks and destroys these insulin-producing cells, leading to high blood sugar levels. Islet transplantation aims to replace the damaged islets with healthy ones from a donor, allowing the recipient's body to produce and regulate its own insulin again.

The procedure involves extracting the islets from the donor pancreas and infusing them into the recipient's liver through a small incision in the abdomen. Once inside the liver, the islets can sense glucose levels in the bloodstream and release insulin as needed to maintain normal blood sugar levels.

Islet transplantation has shown promising results in improving blood sugar control and reducing the risk of severe hypoglycemia (low blood sugar) in people with type 1 diabetes. However, it requires long-term immunosuppressive therapy to prevent rejection of the transplanted islets, which can have side effects and increase the risk of infections.

Amyloid beta-peptides (Aβ) are small protein fragments that are crucially involved in the pathogenesis of Alzheimer's disease. They are derived from a larger transmembrane protein called the amyloid precursor protein (APP) through a series of proteolytic cleavage events.

The two primary forms of Aβ peptides are Aβ40 and Aβ42, which differ in length by two amino acids. While both forms can be harmful, Aβ42 is more prone to aggregation and is considered to be the more pathogenic form. These peptides have the tendency to misfold and accumulate into oligomers, fibrils, and eventually insoluble plaques that deposit in various areas of the brain, most notably the cerebral cortex and hippocampus.

The accumulation of Aβ peptides is believed to initiate a cascade of events leading to neuroinflammation, oxidative stress, synaptic dysfunction, and neuronal death, which are all hallmarks of Alzheimer's disease. Although the exact role of Aβ in the onset and progression of Alzheimer's is still under investigation, it is widely accepted that they play a central part in the development of this debilitating neurodegenerative disorder.

Thiazoles are organic compounds that contain a heterocyclic ring consisting of a nitrogen atom and a sulfur atom, along with two carbon atoms and two hydrogen atoms. They have the chemical formula C3H4NS. Thiazoles are present in various natural and synthetic substances, including some vitamins, drugs, and dyes. In the context of medicine, thiazole derivatives have been developed as pharmaceuticals for their diverse biological activities, such as anti-inflammatory, antifungal, antibacterial, and antihypertensive properties. Some well-known examples include thiazide diuretics (e.g., hydrochlorothiazide) used to treat high blood pressure and edema, and the antidiabetic drug pioglitazone.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Serum Amyloid A (SAA) protein is an acute phase protein produced primarily in the liver, although it can also be produced by other cells in response to inflammation. It is a member of the apolipoprotein family and is found in high-density lipoproteins (HDL) in the blood. SAA protein levels increase rapidly during the acute phase response to infection, trauma, or tissue damage, making it a useful biomarker for inflammation.

In addition to its role as an acute phase protein, SAA has been implicated in several disease processes, including atherosclerosis and amyloidosis. In amyloidosis, SAA can form insoluble fibrils that deposit in various tissues, leading to organ dysfunction. There are four subtypes of SAA in humans (SAA1, SAA2, SAA3, and SAA4), with SAA1 and SAA2 being the most responsive to inflammatory stimuli.

The pancreas is a glandular organ located in the abdomen, posterior to the stomach. It has both exocrine and endocrine functions. The exocrine portion of the pancreas consists of acinar cells that produce and secrete digestive enzymes into the duodenum via the pancreatic duct. These enzymes help in the breakdown of proteins, carbohydrates, and fats in food.

The endocrine portion of the pancreas consists of clusters of cells called islets of Langerhans, which include alpha, beta, delta, and F cells. These cells produce and secrete hormones directly into the bloodstream, including insulin, glucagon, somatostatin, and pancreatic polypeptide. Insulin and glucagon are critical regulators of blood sugar levels, with insulin promoting glucose uptake and storage in tissues and glucagon stimulating glycogenolysis and gluconeogenesis to raise blood glucose when it is low.

Glucose Transporter Type 2 (GLUT2) is a protein responsible for the facilitated diffusion of glucose across the cell membrane. It is a member of the solute carrier family 2 (SLC2), also known as the facilitative glucose transporter family. GLUT2 is primarily expressed in the liver, kidney, and intestines, where it plays a crucial role in regulating glucose homeostasis.

In the pancreas, GLUT2 is found in the beta cells of the islets of Langerhans, where it facilitates the uptake of glucose from the bloodstream into the cells. Once inside the cell, glucose is metabolized, leading to an increase in ATP levels and the closure of ATP-sensitive potassium channels. This results in the depolarization of the cell membrane and the subsequent opening of voltage-gated calcium channels, allowing for the release of insulin from secretory vesicles into the bloodstream.

In the intestines, GLUT2 is expressed in the enterocytes of the small intestine, where it facilitates the absorption of glucose and other monosaccharides from the lumen into the bloodstream. In the kidneys, GLUT2 is found in the proximal tubules, where it plays a role in reabsorbing glucose from the filtrate back into the bloodstream.

Mutations in the gene that encodes GLUT2 (SLC2A2) can lead to several genetic disorders, including Fanconi-Bickel syndrome, which is characterized by impaired glucose and galactose absorption in the intestines, hepatic glycogen accumulation, and renal tubular dysfunction.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

The Amyloid Beta-Protein Precursor (AβPP) is a type of transmembrane protein that is widely expressed in various tissues and organs, including the brain. It plays a crucial role in normal physiological processes, such as neuronal development, synaptic plasticity, and repair.

AβPP undergoes proteolytic processing by enzymes called secretases, resulting in the production of several protein fragments, including the amyloid-beta (Aβ) peptide. Aβ is a small peptide that can aggregate and form insoluble fibrils, which are the main component of amyloid plaques found in the brains of patients with Alzheimer's disease (AD).

The accumulation of Aβ plaques is believed to contribute to the neurodegeneration and cognitive decline observed in AD. Therefore, AβPP and its proteolytic processing have been the focus of extensive research aimed at understanding the pathogenesis of AD and developing potential therapies.

Protein folding is the process by which a protein molecule naturally folds into its three-dimensional structure, following the synthesis of its amino acid chain. This complex process is determined by the sequence and properties of the amino acids, as well as various environmental factors such as temperature, pH, and the presence of molecular chaperones. The final folded conformation of a protein is crucial for its proper function, as it enables the formation of specific interactions between different parts of the molecule, which in turn define its biological activity. Protein misfolding can lead to various diseases, including neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

Spectrophotometry, Infrared is a scientific analytical technique used to measure the absorption or transmission of infrared light by a sample. It involves the use of an infrared spectrophotometer, which directs infrared radiation through a sample and measures the intensity of the radiation that is transmitted or absorbed by the sample at different wavelengths within the infrared region of the electromagnetic spectrum.

Infrared spectroscopy can be used to identify and quantify functional groups and chemical bonds present in a sample, as well as to study the molecular structure and composition of materials. The resulting infrared spectrum provides a unique "fingerprint" of the sample, which can be compared with reference spectra to aid in identification and characterization.

Infrared spectrophotometry is widely used in various fields such as chemistry, biology, pharmaceuticals, forensics, and materials science for qualitative and quantitative analysis of samples.

Amyloid plaque is a pathological hallmark of several degenerative diseases, including Alzheimer's disease. It refers to extracellular deposits of misfolded proteins that accumulate in various tissues and organs, but are most commonly found in the brain. The main component of these plaques is an abnormally folded form of a protein called amyloid-beta (Aβ). This protein is produced through the normal processing of the amyloid precursor protein (APP), but in amyloid plaques, it aggregates into insoluble fibrils that form the core of the plaque.

The accumulation of amyloid plaques is thought to contribute to neurodegeneration and cognitive decline in Alzheimer's disease and other related disorders. The exact mechanisms by which this occurs are not fully understood, but it is believed that the aggregation of Aβ into plaques leads to the disruption of neuronal function and viability, as well as the activation of inflammatory responses that can further damage brain tissue.

It's important to note that while amyloid plaques are a key feature of Alzheimer's disease, they are not exclusive to this condition. Amyloid plaques have also been found in other neurodegenerative disorders, as well as in some normal aging brains, although their significance in these contexts is less clear.

Circular dichroism (CD) is a technique used in physics and chemistry to study the structure of molecules, particularly large biological molecules such as proteins and nucleic acids. It measures the difference in absorption of left-handed and right-handed circularly polarized light by a sample. This difference in absorption can provide information about the three-dimensional structure of the molecule, including its chirality or "handedness."

In more technical terms, CD is a form of spectroscopy that measures the differential absorption of left and right circularly polarized light as a function of wavelength. The CD signal is measured in units of millidegrees (mdeg) and can be positive or negative, depending on the type of chromophore and its orientation within the molecule.

CD spectra can provide valuable information about the secondary and tertiary structure of proteins, as well as the conformation of nucleic acids. For example, alpha-helical proteins typically exhibit a strong positive band near 190 nm and two negative bands at around 208 nm and 222 nm, while beta-sheet proteins show a strong positive band near 195 nm and two negative bands at around 217 nm and 175 nm.

CD spectroscopy is a powerful tool for studying the structural changes that occur in biological molecules under different conditions, such as temperature, pH, or the presence of ligands or other molecules. It can also be used to monitor the folding and unfolding of proteins, as well as the binding of drugs or other small molecules to their targets.

Electron microscopy (EM) is a type of microscopy that uses a beam of electrons to create an image of the sample being examined, resulting in much higher magnification and resolution than light microscopy. There are several types of electron microscopy, including transmission electron microscopy (TEM), scanning electron microscopy (SEM), and reflection electron microscopy (REM).

In TEM, a beam of electrons is transmitted through a thin slice of the sample, and the electrons that pass through the sample are focused to form an image. This technique can provide detailed information about the internal structure of cells, viruses, and other biological specimens, as well as the composition and structure of materials at the atomic level.

In SEM, a beam of electrons is scanned across the surface of the sample, and the electrons that are scattered back from the surface are detected to create an image. This technique can provide information about the topography and composition of surfaces, as well as the structure of materials at the microscopic level.

REM is a variation of SEM in which the beam of electrons is reflected off the surface of the sample, rather than scattered back from it. This technique can provide information about the surface chemistry and composition of materials.

Electron microscopy has a wide range of applications in biology, medicine, and materials science, including the study of cellular structure and function, disease diagnosis, and the development of new materials and technologies.

A lipid bilayer is a thin membrane made up of two layers of lipid molecules, primarily phospholipids. The hydrophilic (water-loving) heads of the lipids face outwards, coming into contact with watery environments on both sides, while the hydrophobic (water-fearing) tails point inward, away from the aqueous surroundings. This unique structure allows lipid bilayers to form a stable barrier that controls the movement of molecules and ions in and out of cells and organelles, thus playing a crucial role in maintaining cellular compartmentalization and homeostasis.

Atomic Force Microscopy (AFM) is a type of microscopy that allows visualization and measurement of surfaces at the atomic level. It works by using a sharp probe, called a tip, that is mounted on a flexible cantilever. The tip is brought very close to the surface of the sample and as the sample is scanned, the forces between the tip and the sample cause the cantilever to deflect. This deflection is measured and used to generate a topographic map of the surface with extremely high resolution, often on the order of fractions of a nanometer. AFM can be used to study both conductive and non-conductive samples, and can operate in various environments, including air and liquid. It has applications in fields such as materials science, biology, and chemistry.

... inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism, ACS Chem. Biol. 2015; 10: 1555- ... These complexes are a subset of macrocyclic molecular receptors and their structure is that the two "arms" that bind the guest ... islet amyloid polypeptide (amylin), which kills pancreatic β-cells in type-2 diabetes; transthyretin (TTR), which causes ... Amyloid β-protein Assembly: The Effect of Molecular Tweezer CLR01 and CLR03. J. Phys. Chem. B, 2015; 119: 4831-4841. S ...
2001). "The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal ... 2000). "Interactions between the prohormone convertase 2 promoter and the thyroid hormone receptor". Endocrinology. 141 (9): ...
Amylin, also known as islet amyloid polypeptide (IAPP). The function of amylin is to slow the rate of glucose entering the ... Gastric inhibitory polypeptide receptor List of terms associated with diabetes Guangxitoxin Alpha cell Pancreatic development ... It is believed to be due to the decline of specific receptors on the surface of the liver, adipose, and muscle cells which lose ... Beta cells make up 50-70% of the cells in human islets. In patients with Type 1 diabetes, beta-cell mass and function are ...
Amyloid deposits deriving from islet amyloid polypeptide (IAPP, or amylin) are commonly found in pancreatic islets of patients ... All three complexes contain the calcitonin receptor at the core, plus one of three receptor activity-modifying proteins, RAMP1 ... "Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid ... "Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic ...
Nishi, M.; Steiner, D. (2003). "Cloning of complementary DNA's encoding islet amyloid polypeptide, insulin, and glucagon ... separation-induced receptor changes in the prefrontal cortex of Octodon degus", Neuroscience, 119 (2): 433-441, doi:10.1016/ ... 2004), "Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degus", Neurobiol. ...
Lin CY, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC (May 2007). "Toxic human islet amyloid polypeptide (h-IAPP ... protein receptors, soluble proteins, RNAs, small metabolites, etc. In the clinical setting, amyloid diseases are typically ... There are multiple classes of amyloid-forming polypeptide sequences. Glutamine-rich polypeptides are important in the ... Wikimedia Commons has media related to Amyloid. Bacterial Inclusion Bodies Contain Amyloid-Like Structure at SciVee Amyloid ...
The CALC1 gene belongs to a superfamily of related protein hormone precursors including islet amyloid precursor protein, ... The calcitonin receptor is a G protein-coupled receptor localized to osteoclasts as well kidney and brain cells. It is coupled ... Calcitonin is a polypeptide hormone of 32 amino acids, with a molecular weight of 3454.93 daltons. Its structure comprises a ... Osteoblasts do not have calcitonin receptors and are therefore not directly affected by calcitonin levels. However, since bone ...
"GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice". ... 5) Ffar1 gene knockout mice had impaired secretion of glucagon-like peptide-1 and gastric inhibitory polypeptide into the ... and pancreatic islets isolated from humans. These fatty acid activators did not have this action in the absence of concurrent ... Free fatty acid receptor 1 (FFAR1), also known as G-protein coupled receptor 40 (GPR40), is a rhodopsin-like G-protein coupled ...
... islet amyloid polypeptide; IDE: insulin-degrading enzyme; IGF: insulin-like growth factor; RAGE: receptor for advanced ... Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimers disease: two triggers, one disease Sofia Ferreira 1 , Ana ... Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimers disease: two triggers, one disease Sofia Ferreira et al. ... Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimers disease. Fawver JN, Ghiwot Y, Koola C, Carrera W, Rodriguez- ...
Receptors, Islet Amyloid Polypeptide / antagonists & inhibitors * Receptors, Islet Amyloid Polypeptide / metabolism * Receptors ... Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake ... We show that mRNA for all components of the amylin receptor complex is expressed in the ventral tegmental area (VTA), a ... VTA amylin receptor activation also reduces sucrose self-administration on a progressive ratio schedule. Finally, antagonist ...
9. Islet amyloid polypeptide stimulates cyclic AMP accumulation via the porcine calcitonin receptor.. Christmanson L; ... Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor ... Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.. Findlay DM; Michelangeli ... Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.. Nakamuta H; Orlowski RC; Epand RM. ...
Amylin Amylin, or islet amyloid polypeptide, is secreted with insulin by β-cells,[147] and patients with Type 1 diabetes are ... Leptin receptors, members of the gp130 family of cytokine receptors, are expressed in the hypothalamus.[175] Leptin receptors ... and amylin receptors appear when calcitonin receptors are coexpressed with receptor activity-modifying proteins.[156,157] ... Histamine receptor antagonist. No study results posted. [333,334]. Metreleptin. Amylin/Takeda. Phase III. Leptin receptor ...
... Islet amyloid polypeptide PDB rendering based on 2g48. Available structures: 2g48 Identifiers Symbol(s) IAPP; IAP; DAP; ... "Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid ... Receptors. There appears to be at least three distinct receptor complexes that bind with high affinity to amylin. All three ... Islet, or insulinoma, amyloid polypeptide (IAPP, or amylin) is commonly found in pancreatic islets of patients suffering ...
Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51:2158- ... Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. ... Estrogen-related receptor γ is an in vivo receptor of bisphenol A , The FASEB Journal, 10.1096/fj.13-240465, 28:7, (3124-3133) ... Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha ...
Receptors, Islet Amyloid Polypeptide Entry term(s). Amylin Receptor Amylin Receptors IAPP Receptor Islet Amyloid Polypeptide ... Amylin Receptors. IAPP Receptor. Islet Amyloid Polypeptide Receptor. Receptor, Amylin. Receptor, IAPP. Receptors, Amylin. ... agonists:Amylin Receptor Agonists Public MeSH Note:. 2011; AMYLIN RECEPTOR (now RECEPTORS, ISLET AMYLOID POLYPEPTIDE) was ... Receptors, Islet Amyloid Polypeptide - Preferred Concept UI. M0541731. Scope note. G-protein coupled receptors that are formed ...
Amylin Receptor Amylin Receptors IAPP Receptor Islet Amyloid Polypeptide Receptor Receptor, Amylin Registry Number. 0. Public ... 2011; AMYLIN RECEPTOR (now RECEPTORS, ISLET AMYLOID POLYPEPTIDE) was indexed under RECEPTORS, PEPTIDE 1994-2010, and under ... Receptors, Islet Amyloid Polypeptide Preferred Term Term UI T762487. Date12/14/2009. LexicalTag NON. ThesaurusID NLM (2011). ... Islet Amyloid Polypeptide Receptor Term UI T762493. Date12/14/2009. LexicalTag NON. ThesaurusID NLM (2011). ...
Amylin Receptor Amylin Receptors IAPP Receptor Islet Amyloid Polypeptide Receptor Receptor, Amylin Registry Number. 0. Public ... 2011; AMYLIN RECEPTOR (now RECEPTORS, ISLET AMYLOID POLYPEPTIDE) was indexed under RECEPTORS, PEPTIDE 1994-2010, and under ... Receptors, Islet Amyloid Polypeptide Preferred Term Term UI T762487. Date12/14/2009. LexicalTag NON. ThesaurusID NLM (2011). ... Islet Amyloid Polypeptide Receptor Term UI T762493. Date12/14/2009. LexicalTag NON. ThesaurusID NLM (2011). ...
Islet Amyloid Polypeptide Receptor 62% * calcitonin gene-related peptide (8-37) 53% ... Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Hay, D. L., Christopoulos ... Noncovalent coatings for the separation of synthetic polypeptides by nonaqueous capillary electrophoresis. Vayaboury, W., Kirby ... Peptide recognition by the T cell receptor: comparison of binding free energies from thermodynamic integration, Poisson- ...
Pramlintide response is mediated through upregulation of islet amyloid polypeptide (IAPP). Here, we showed that osteosarcoma ... Reactivation of NRF2 signaling, conditional deletion of STING, or blockade of type I interferon receptor I restored the ... cells have altered p63, p73, and p53, and decreased IAPP expression but have the two main IAPP receptors, CalcR and RAMP3, ...
Molecular tweezers inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism, ACS Chem. Biol. 2015; 10: 1555- ... These complexes are a subset of macrocyclic molecular receptors and their structure is that the two "arms" that bind the guest ... islet amyloid polypeptide (amylin), which kills pancreatic β-cells in type-2 diabetes; transthyretin (TTR), which causes ... Amyloid β-protein Assembly: The Effect of Molecular Tweezer CLR01 and CLR03. J. Phys. Chem. B, 2015; 119: 4831-4841. S ...
Receptors, Histamine H2. *Receptors, Islet Amyloid Polypeptide. *Receptors, LH. *Receptors, LHRH. *Receptors, Lysophospholipid ... "Receptors, Formyl Peptide" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... A family of G-protein-coupled receptors that was originally identified by its ability to bind N-formyl peptides such as N- ... Since N-formyl peptides are found in MITOCHONDRIA and BACTERIA, this class of receptors is believed to play a role in mediating ...
... amphotericin B N0000169268 Serum Amyloid A Protein N0000169267 Serum Amyloid P-Component N0000182046 Islet Amyloid Polypeptide ... Receptor N0000175261 Xedar Receptor N0000175262 Edar Receptor N0000168756 Toll-Like Receptor 1 N0000182134 Folate Receptor 1 ... IDL N0000171274 Receptors, IgE N0000168822 Receptor, IGF Type 1 N0000168823 Receptor, IGF Type 2 N0000171297 Receptors, IgG ... Eph Family N0000168800 Receptor, EphA1 N0000168803 Receptor, EphA2 N0000168805 Receptor, EphA3 N0000168810 Receptor, EphA4 ...
Included under this heading is the endogenous form of ISLET AMYLOID POLYPEPTIDE and synthetic compounds that mimic its effect. ... Epiregulin has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR. HN - 2015 MH - ErbB Receptors UI - D066246 MN - D8.811 ... HN - 2015 BX - Receptors, Epidermal Growth Factor-Urogastrone FX - Genes, erbB MH - Estrogen Receptor Antagonists UI - D065171 ... Betacellulin has specificity for the EGF RECEPTOR and the ERBB-4 RECEPTOR. HN - 2015 MH - Bioprospecting UI - D065132 MN - ...
Included under this heading is the endogenous form of ISLET AMYLOID POLYPEPTIDE and synthetic compounds that mimic its effect. ... "Amylin Receptor Agonists" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... This graph shows the total number of publications written about "Amylin Receptor Agonists" by people in this website by year, ... Below are the most recent publications written about "Amylin Receptor Agonists" by people in Profiles. ...
Calcitonin activates calcitonin receptor (CALCR) in a dose-dependent manner (Figure). Available assay modes and other details ... occasionally called islet-amyloid polypeptide, diabetes-associated polypeptide), adrenomedullin and adrenomedullin 2/intermedin ... by the genes CALCR (which codes for the CT receptor) and CALCRL (which codes for the calcitonin receptor-like receptor, CLR, ... Calcitonin receptors. This receptor family comprises a group of receptors for the calcitonin/CGRP family of peptides. The ...
Type 2 diabetes is often accompanied by large deposits of amyloid fibrils (IAPP, islet amyloid polypeptide) in and around the ... These include tagged antibodies to the beta cell surface, ligands for receptors specific to the beta cell, or agents whose ... It would be of great benefit to the diabetes community to be able to image the beta cells of the pancreatic islets. Insulin is ... Blood flow through the microcirculation near the islet cells is increased in response to glucose and may provide a measure of ...
Receptors, Histamine H4 [D12.776.543.750.695.358] * Receptors, Islet Amyloid Polypeptide [D12.776.543.750.695.360] ... Receptors, SRIH Receptors, Somatotropin Release Inhibiting Hormone SRIH Receptors Somatostatin Receptor Somatostatin Receptors ... Receptors, Pheromone [D12.776.543.750.695.660] * Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide [D12.776.543.750 ... Receptors, Cell Surface [D12.776.543.750] * Receptors, G-Protein-Coupled [D12.776.543.750.695] * Apelin Receptors [D12.776. ...
Amyloid is defined as in vivo deposited material distinguished by the following: Fibrillar appearance on electron micrography ... In islet amyloid polypeptide amyloidosis (AIAPP), the precursor protein is an islet amyloid polypeptide (IAPP), also known as ... 57] The IL-1β receptor antagonist anakinra has been shown to improve the signs and symptoms in MWS by decreasing serum (hsCRP ... 3] However, amyloid fibrils can have different protofilament numbers, arrangements, and polypeptide conformations. [4] It is ...
Type 2 diabetes is often accompanied by large deposits of amyloid fibrils (IAPP, islet amyloid polypeptide) in and around the ... These include tagged antibodies to the beta cell surface, ligands for receptors specific to the beta cell, or agents whose ... It would be of great benefit to the diabetes community to be able to image the beta cells of the pancreatic islets. Insulin is ... o Evaluation of whether or not the IAPP inclusions in the pancreatic islets in type 2 diabetes can be visualized. o Development ...
Islet Amyloid Polypeptide 28% * Proteolytic rewiring of mitochondria by LONP1 directs cell identity switching of adipocytes. Fu ... Structural basis of the alkaline pH-dependent activation of insulin receptor-related receptor. Wang, L., Hall, C., Li, J., Choi ... Reply to: The G protein preference of orexin receptors is currently an unresolved issue. Yin, J., Kang, Y., McGrath, A. P., ... The Activation Mechanism of the Insulin Receptor: A Structural Perspective. Choi, E. & Bai, X. C., Jun 20 2023, In: Annual ...
islet amyloid polypeptide. multiple interactions. EXP. Verapamil inhibits the reaction [Glucose results in increased expression ... dopamine receptor D1. multiple interactions. ISO. Verapamil inhibits the reaction [SCH 23390 binds to DRD1 protein]. CTD. PMID: ... dopamine receptor D2. multiple interactions. ISO. Verapamil inhibits the reaction [Raclopride binds to DRD2 protein]. CTD. PMID ... nuclear receptor subfamily 1, group I, member 2. increases activity. multiple interactions. ISO. Verapamil results in increased ...
Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of ... Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of ... The CCK receptor agonist caerulein (CRN, Glbiochem, Shanghai) reconstituted in saline was used to induce acute experimental ... Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, Mannucci E. Safety issues with glucagon-like peptide-1 receptor ...
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A. 1996;93( ... Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that ... elevated amyloid severity measured as the total amyloid per islet area and amyloid prevalence measured as the number of islets ... Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J. 2006;47(3):225-233.. View this ...
Receptors, Histamine H2. *Receptors, Islet Amyloid Polypeptide. *Receptors, LH. *Receptors, LHRH. *Receptors, Lysophospholipid ... A class of G-protein-coupled receptors that react to varying extracellular CALCIUM levels. Calcium-sensing receptors in the ... "Receptors, Calcium-Sensing" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... Wu S, Palese T, Mishra OP, Delivoria-Papadopoulos M, De Luca F. Effects of Ca2+ sensing receptor activation in the growth plate ...
Receptors, Islet Amyloid Polypeptide. *Receptors, Kisspeptin-1. *Receptors, LH. *Receptors, LHRH. *Receptors, Lysophospholipid ... Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic ... Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of ... Huang H, He X, Deng X, Li G, Ying G, Sun Y, Shi L, Benovic JL, Zhou N. Bombyx adipokinetic hormone receptor activates ...
Novel Human Islet Amyloid Polypeptides as Alzheimers Disease Biomarkers and Inhibitors of Amyloid Formation *Read more about ... Ephrin (Eph) receptors are a clinically relevant class of receptor tyrosine kinases. Related signaling pathways are associated ... A hallmark feature of T2DM is the accumulation of islet amyloid polypeptide fibrils in pancreatic islets. Such accumulations ... whereas aggregation of mature islet amyloid polypeptide (IAPP37) in human islet leads to β-cell dysfunction. ...
  • 1 A new paper 1 reports on how the loss of autophagy along with beta cell expression of IAPP (amyloid islet polypeptide, also called amylin), a 37 amino acid protein coexpressed and released by pancreatic beta cells along with insulin, results in the death (apoptosis) of beta cells. (life-enhancement.com)
  • Amylin, or islet amyloid polypeptide ( IAPP ), is a 37-residue peptide hormone . (wikidoc.org)
  • Proislet amyloid polypeptide (proIAPP, proamylin, proislet protein) is produced in the pancreatic beta cells (β-cells) as a 67 amino acid, 7404 Dalton pro-peptide and undergoes post-translational modifications including protease cleavage to produce amylin. (wikidoc.org)
  • Inhibition of the IAPP receptor with the antagonist AC187 only reverted IAPP effects partially. (lu.se)
  • The focus of Dr. Berg's work is on the signaling proteins and pathways regulating T lymphocyte development, differentiation, activation, and migration, with a strong emphasis on T-cell receptor (TCR) signaling. (cuanschutz.edu)
  • I am currently studying novel roles of complement proteins, with focuses on C3 and CD59 and how they affect cellular function in various systems, with particular focus within the pancreatic islet. (lu.se)
  • Amyloidosis results from the accumulation of pathogenic amyloids-most of which are aggregates of misfolded proteins-in a variety of tissues. (medscape.com)
  • [ 5 ] Only 10% of amyloidosis deposits consist of components such as glycosaminoglycans (GAGs), apolipoprotein-E (apoE), and serum amyloid P-component (SAP), while nearly 90% of the deposits consist of amyloid fibrils that are formed by the aggregation of misfolded proteins. (medscape.com)
  • [ 6 ] In humans, about 23 different unrelated proteins are known to form amyloid fibrils in vivo. (medscape.com)
  • In pancreatic islets, SORLA acts as clearance receptor for proIAPP co-secreted with IAPP (steps 1-3), reducing fibril deposits in T2D (step 4). (mdc-berlin.de)
  • SORLA directs re-uptake and lysosomal catabolism of proIAPP, but not IAPP (steps 2 and 3), counteracting amyloid deposition from proIAPP without compromising active hormone function (step 4) (Shih et al. (mdc-berlin.de)
  • Title: Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates. (aablocks.com)
  • Polymorphisms that slightly vary native peptides or inflammatory processes set the stage for abnormal protein folding and amyloid fibril deposition. (medscape.com)
  • In case of insulin hypersecretion, as in T2D, excessive amounts of IAPP are released and deposited as fibrils that further compromise islet function. (mdc-berlin.de)
  • Title: Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers. (aablocks.com)
  • The conformational ensemble also reveals that in nearly half of the structural core of this amyloid fibril, the side chains exhibit liquid-like dynamics despite the presence of the highly ordered network backbone of hydrogen bonds characteristic of the cross-beta structure of amyloid fibrils. (stanford.edu)
  • Amyloid fibrils are protein polymers comprising identical monomer units (homopolymers). (medscape.com)
  • Amyloidosis is a clinical disorder caused by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alter the normal function of tissues. (medscape.com)
  • The modern era of amyloidosis classification began in the late 1960s with the development of methods to solubilize amyloid fibrils. (medscape.com)
  • Dr. Benninger's research focuses on understanding the mechanisms underlying pancreatic islet function and decline in type1 and type2 diabetes. (cuanschutz.edu)
  • Amyloid deposits in the pancreas are composed of islet amyloid polypeptide (IAPP), a peptide hormone co-secreted with insulin. (mdc-berlin.de)
  • Description: A sandwich ELISA kit for detection of G Protein Coupled Receptor 172A from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (myelisakit.com)
  • Our studies were guided by our earlier work that SORLA acts as a sorting factor for the insulin receptor (IR) in adipose tissue (Schmidt et al. (mdc-berlin.de)
  • Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Insulin Receptor (ISR) in serum, plasma, tissue homogenates and other biological fluids. (tuberculosistest.net)
  • Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Insulin Receptor (ISR) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. (tuberculosistest.net)
  • Description: A sandwich quantitative ELISA assay kit for detection of Rat Insulin Receptor (ISR) in samples from serum, plasma, tissue homogenates or other biological fluids. (tuberculosistest.net)
  • Moreover, in cultured cells in vitro and in transgenic mice in vivo, PC-1 overexpression impairs insulin stimulation of insulin receptor (IR) activation and downstream signaling. (cnr.it)
  • Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. (harvard.edu)
  • A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. (ouhsc.edu)
  • Such novel pathways include induction of mitochondrial stress, inhibition of mitochondrial shuttles, alteration of intestinal microbiota, suppression of glucagon signaling, activation of autophagy, attenuation of inflammasome activation, induction of incretin receptors and reduction of terminal endoplasmic reticulum stress. (cyberleninka.org)
  • A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia. (rakmhsu.ac.ae)
  • Figure 3: Macrophage content and Nlrp3 expression in islets of lean and diabetic rats. (nature.com)
  • G-protein coupled receptors that are formed through the dimerization of the CALCITONIN RECEPTOR with a RECEPTOR ACTIVITY-MODIFYING PROTEIN. (uchicago.edu)
  • calcitonin receptor like recepto. (gsea-msigdb.org)
  • Their affinity for ISLET AMYLOID POLYPEPTIDE is dependent upon which of several receptor activity-modifying protein subtypes they are bound to. (uchicago.edu)
  • They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS. (ouhsc.edu)
  • In this study, the long binding helix of this ligand was downsized to an enzymatically stable cyclic peptide endowed with sub-nanomolar binding affinity toward the αvβ6 receptor and remarkable selectivity against other integrins. (cipsm.de)
  • The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter. (nih.gov)
  • Here we show that beta cell failure in adult ZDF rats is not associated with CB 1 R signaling in beta cells, but rather in M1 macrophages infiltrating into pancreatic islets, and that this leads to activation of the Nlrp3-ASC inflammasome in the macrophages. (nature.com)
  • Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. (nature.com)
  • In the paper (Rivera, 2014) the researchers report on their experiments with rodent beta cell islets, showing that when autophagy was stimulated by the autophagy-inducing drug rapamycin that (at the dose used) beta cell IAPP content was reduced by 54% ±5.5% versus untreated (no rapamycin) cells. (life-enhancement.com)
  • Many studies have shown that activation of islet autophagy may enhance antioxidant response, leading to reduced oxidative stress and reduced apoptosis in high glucose stress [ 15 , 16 ]. (hindawi.com)
  • Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism. (uu.se)
  • Title: Alzheimer's disease and the amyloid cascade hypothesis: a critical review. (aablocks.com)
  • Molecular signaling of G-protein-coupled receptor in chronic heart failure and associated complications. (rakmhsu.ac.ae)
  • Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human G Protein Coupled Receptor 172A (GPR172A) in Tissue homogenates, saliva and other biological fluids. (myelisakit.com)
  • Description: A sandwich quantitative ELISA assay kit for detection of Human G Protein Coupled Receptor 120 (GPR120) in samples from tissue homogenates, cell lysates or other biological fluids. (myelisakit.com)
  • SORLA shuttles internalized insulin receptors back to the cell surface (steps 1 and 3), bypassing lysosomal degradation (step 2) and sensitizing cells for insulin signaling (step 4). (mdc-berlin.de)
  • The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. (harvard.edu)
  • The receptor is normally avoided by This technique from time for the cell surface area, where in fact the receptor could remove even more LDL particles. (researchensemble.com)
  • The present study was designed to determine the relative influence of intraislet somatostatin on the regulation of islet amyloid polypeptide (IAPP) and insulin secretion, and to determine the effect of specific somatostatin receptor (SSTR) agonists on beta cell secretion during immunoneutralization of endogenous somatostatin in the isolated perfused human pancreas. (uaeu.ac.ae)
  • The islet amyloid polypeptide (IAPP), a pancreas-produced peptide, has beneficial functions in its monomeric form. (lu.se)
  • SORLA is a 250 kDa receptor expressed in brain but also metabolic tissues, including visceral fat and pancreas. (mdc-berlin.de)
  • Figure 4: Effects of macrophage depletion on glycemic control and proinflammatory signaling in islets of ZDF rats. (nature.com)
  • Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. (ouhsc.edu)
  • Voinsky I, Bennuri SC, Svigals J, Frye RE, Rose S, Gurwitz D. Peripheral Blood Mononuclear Cell Oxytocin and Vasopressin Receptor Expression Positively Correlates with Social and Behavioral Function in Children with Autism. (uams.edu)
  • Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. (nih.gov)
  • Determination of the Structure and Dynamics of the Fuzzy Coat of an Amyloid Fibril of IAPP Using Cryo-Electron Microscopy. (stanford.edu)
  • To illustrate the method, we apply it to elucidate the dynamics of an amyloid fibril of the islet amyloid polypeptide (IAPP). (stanford.edu)
  • The resulting conformational ensemble provides an accurate description of the structural variability of the disordered region of the amyloid fibril, known as fuzzy coat. (stanford.edu)
  • The amyloidoses are referred to with a capital A (for amyloid) followed by an abbreviation for the fibril protein. (medscape.com)
  • Type 2 diabetes (T2D) is a major risk factor for AD and both diseases share pathological hallmarks, including amyloid deposits that compromise cell viability and function. (mdc-berlin.de)
  • [ 2 ] Many classic eponymic diseases were later found to be related to a diverse array of misfolded polypeptides (amyloid) that contain the common beta-pleated sheet architecture. (medscape.com)
  • Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (uchicago.edu)
  • Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. (uams.edu)
  • Given the expression of SORLA in islet β-cells, we reasoned that the receptor may have a similar protective function as in the brain, counteracting islet amyloid deposition. (mdc-berlin.de)
  • In earlier work, we focused on a role of the receptor in neurons, showing association of the encoding gene SORL1 with the common sporadic form of AD (Rogeava et al. (mdc-berlin.de)
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (ouhsc.edu)
  • This graph shows the total number of publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" by people in this website by year, and whether "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" was a major or minor topic of these publications. (ouhsc.edu)
  • Below are the most recent publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide" by people in Profiles. (ouhsc.edu)
  • More interestingly, since the rodent form of IAPP does not form amyloidogenic aggregated, misfolded cytotoxic deposits, the researchers duplicated their experiments using HUMAN islets and found that rapamycin decreased IAPP content by 31% ±12.4% as compared to untreated human islets. (life-enhancement.com)
  • Various descriptive classification systems were proposed based on the organ distribution of amyloid deposits and clinical findings. (medscape.com)
  • SUs bind to their receptors (sulfonylurea receptor 1, SUR1), which are the regulatory subunits of the ATP-dependent potassium (K ATP ) channel. (hindawi.com)
  • A class of histamine receptors discriminated by their pharmacology and mode of action. (uchicago.edu)
  • Functional amyloids play a beneficial role in a variety of physiologic processes (eg, long-term memory formation, gradual release of stored peptide hormones). (medscape.com)
  • Methamphetamine decreases K+ channel function in human fetal astrocytes by activating the trace amine-associated receptor type-1. (rush.edu)
  • Figure 6: Proinflammatory gene and protein expression in human macrophages and rat and human isolated islets treated with AEA, IL-1β or high glucose. (nature.com)
  • In particular, we see that expression of CD59 and C3 are altered in islets from human donors with diabetes, compared to healthy donors. (lu.se)
  • These complexes are a subset of macrocyclic molecular receptors and their structure is that the two "arms" that bind the guest molecule between them are only connected at one end leading to a certain flexibility of these receptor molecules (induced fit model). (wikipedia.org)
  • That makes this overall class of macromolecule truly synthetic molecular receptors with important application to biology and medicine. (wikipedia.org)
  • In turn, these entail alterations in leptin sensitivity, leptin transport across the blood-brain barrier and defects in post-receptor signaling. (unab.cl)
  • EMBO J 2012), and we corroborated pharmacological induction of receptor expression as a therapeutic option in AD (Rohe et al. (mdc-berlin.de)
  • The relaxin receptor RXFP1 signals through a mechanism of autoinhibition. (harvard.edu)
  • Increased number of islet-associated macrophages in type 2 diabetes. (nature.com)
  • A major focus has been understanding the role of intra-islet communication and functional sub-populations of cells in islet function, and how disruption to intra-islet communication mechanisms and changes in sub-populations occur in diabetes and may contribute to islet decline. (cuanschutz.edu)
  • Complimentary to these studies, Dr Benninger's lab is also developing ultrasound-based imaging diagnostics for non-invasively detecting islet decline in pre-symptomatic diabetes and as a platform for image-guided drug delivery. (cuanschutz.edu)
  • Profundice en los temas de investigación de 'Is "Leptin Resistance" Another Key Resistance to Manage Type 2 Diabetes? (unab.cl)
  • glycine receptor beta [Source:HG. (gsea-msigdb.org)
  • Endocannabinoids contribute to insulin resistance through activation of peripheral CB 1 receptors (CB 1 Rs) and also promote beta cell failure. (nature.com)
  • arginine vasopressin receptor 1A. (gsea-msigdb.org)
  • Srivastava R, Cornett LE, Chaturvedi CM. Impact of estrogen and photoperiod on arginine vasotocin and VT3 receptor expression in the shell gland of quail. (uams.edu)
  • Title: Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence. (aablocks.com)
  • In addition, we found that isolated islets from Chop -/- mice displayed increased expression of UPR and oxidative stress response genes and reduced levels of oxidative damage. (jci.org)

No images available that match "receptors islet amyloid polypeptide"